Oppenheimer Asset Management Inc. Incyte Corp Transaction History

Oppenheimer Asset Management Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$63.34 - $74.11 $515,017 - $602,588	-8,131 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $110,284 - $134,936	-1,606 Reduced 16.49%	8,131 $559,000
Q2 2021 Aug 03, 2021	SELL	$79.87 - $87.53 $46,644 - $51,117	-584 Reduced 5.66%	9,737 $819,000
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $65,377 - $86,430	-860 Reduced 7.69%	10,321 $839,000
Q4 2020 Feb 11, 2021	SELL	$80.74 - $97.7 $39,885 - $48,263	-494 Reduced 4.23%	11,181 $972,000
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $993,192 - $1.28 Million	11,675 New	11,675 $1.05 Million
Q2 2020 Aug 11, 2020	SELL	$74.18 - $108.93 $63,868 - $93,788	-861 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$63.18 - $85.97 $63 - $85	-1 Reduced 0.12%	861 $63,000
Q4 2019 Feb 07, 2020	BUY	$73.04 - $95.72 $40,902 - $53,603	560 Added 185.43%	862 $75,000
Q3 2019 Oct 31, 2019	SELL	$72.82 - $86.52 $3,349 - $3,979	-46 Reduced 13.22%	302 $22,000
Q1 2019 Apr 24, 2019	BUY	$63.56 - $88.17 $635 - $881	10 Added 2.96%	348 $30,000
Q4 2018 Jan 30, 2019	BUY	$58.5 - $69.94 $19,773 - $23,639	338 New	338 $21,000
Q2 2018 Aug 10, 2018	SELL	$60.85 - $83.98 $1.55 Million - $2.15 Million	-25,546 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$83.06 - $100.98 $72,262 - $87,852	-870 Reduced 3.29%	25,546 $2.13 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $2.88 Million - $3.65 Million	26,416	26,416 $3.08 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.